This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020 Jul 09;383(2):120–128. https://doi.org/10.1056/NEJMoa2015432AckermannMVerledenSEKuehnelMHaverichAWelteTLaengerFVanstapelAWerleinCStarkHTzankovAet alPulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19N Engl J Med2020Jul 093832120128https://doi.org/10.1056/NEJMoa2015432Open DOISearch in Google Scholar
Aguilar-Shea AL, Vera-García M, Güerri-Fernández R. Rapid antigen tests for the detection of SARS-CoV-2: A narrative review. Aten Primaria. 2021 Nov;53(9):102127. https://doi.org/10.1016/j.aprim.2021.102127Aguilar-SheaALVera-GarcíaMGüerri-FernándezRRapid antigen tests for the detection of SARS-CoV-2: A narrative reviewAten Primaria2021Nov539102127https://doi.org/10.1016/j.aprim.2021.102127Open DOISearch in Google Scholar
Alsharif W, Qurashi A. Effectiveness of COVID- 19 diagnosis and management tools: A review. Radiography. 2021 May;27(2):682–687. https://doi.org/10.1016/j.radi.2020.09.010AlsharifWQurashiAEffectiveness of COVID- 19 diagnosis and management tools: A reviewRadiography2021May272682687https://doi.org/10.1016/j.radi.2020.09.010Open DOISearch in Google Scholar
Araf Y, Akter F, Tang Y, Fatemi R, Parvez MSA, Zheng C, Hos‑ sain MG. Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines. J Med Virol. 2022 May;94(5):1825–1832. https://doi.org/10.1002/jmv.27588ArafYAkterFTangYFatemiRParvezMSAZhengCHos‑sain MGOmicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccinesJ Med Virol2022May94518251832https://doi.org/10.1002/jmv.27588Open DOISearch in Google Scholar
Asghari A, Naseri M, Safari H, Saboory E, Parsamanesh N. The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options. DNA Cell Biol. 2020 Oct 01;39(10):1741–1753. https://doi.org/10.1089/dna.2020.5703AsghariANaseriMSafariHSabooryEParsamaneshNThe novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic optionsDNA Cell Biol2020Oct 01391017411753https://doi.org/10.1089/dna.2020.5703Open DOISearch in Google Scholar
Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020 Jun 05;12(11):10087–10098. https://doi.org/10.18632/aging.103415AsseltaRParaboschiEMMantovaniADugaSACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in ItalyAging (Albany NY)2020Jun 0512111008710098https://doi.org/10.18632/aging.103415Open DOISearch in Google Scholar
Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, Bartlett RH, Tonna JE, Hyslop R, Fanning JJ, et al.; Extra‑ corporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020 Oct;396(10257):1071–1078. https://doi.org/10.1016/S0140-6736(20)32008-0BarbaroRPMacLarenGBoonstraPSIwashynaTJSlutskyASFanEBartlettRHTonnaJEHyslopRFanningJJet alExtra‑ corporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registryLancet2020Oct3961025710711078https://doi.org/10.1016/S0140-6736(20)32008-0Open DOISearch in Google Scholar
Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012 Jun 20;4(6):1011–1033. https://doi.org/10.3390/v4061011BelouzardSMilletJKLicitraBNWhittakerGRMechanisms of coronavirus cell entry mediated by the viral spike proteinViruses2012Jun 204610111033https://doi.org/10.3390/v4061011339735922816037Open DOISearch in Google Scholar
Blain H, Rolland Y, Benetos A, Giacosa N, Albrand M, Miot S, Bousquet J. Atypical clinical presentation of COVID- 19 infection in residents of a long-term care facility. Eur Geriatr Med. 2020 Dec;11(6):1085–1088. https://doi.org/10.1007/s41999-020-00352-9BlainHRollandYBenetosAGiacosaNAlbrandMMiotSBousquetJAtypical clinical presentation of COVID- 19 infection in residents of a long-term care facilityEur Geriatr Med2020Dec11610851088https://doi.org/10.1007/s41999-020-00352-9753826533025500Open DOISearch in Google Scholar
Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID- 19. Am J Infect Control. 2021 Jan;49(1):21–29. https://doi.org/10.1016/j.ajic.2020.07.011BögerBFachiMMVilhenaROCobreAFToninFSPontaroloRSystematic review with meta-analysis of the accuracy of diagnostic tests for COVID- 19Am J Infect Control2021Jan4912129https://doi.org/10.1016/j.ajic.2020.07.011735078232659413Open DOISearch in Google Scholar
Brümmer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, Grilli M, Larmann J, Weigand MA, Pollock NR, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLoS Med. 2021 Aug 12;18(8):e1003735. https://doi.org/10.1371/journal.pmed.1003735BrümmerLEKatzenschlagerSGaeddertMErdmannCSchmitzSBotaMGrilliMLarmannJWeigandMAPollockNRet alAccuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysisPLoS Med2021Aug 12188e1003735https://doi.org/10.1371/journal.pmed.1003735838984934383750Open DOISearch in Google Scholar
Bwire GM, Majigo MV, Njiro BJ, Mawazo A. Detection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysis. J Med Virol. 2021 Feb; 93(2):719–725. https://doi.org/10.1002/jmv.26349BwireGMMajigoMVNjiroBJMawazoADetection profile of SARS‐CoV‐2 using RT‐PCR in different types of clinical specimens: A systematic review and meta‐analysisJ Med Virol2021Feb932719725https://doi.org/10.1002/jmv.26349740490432706393Open DOISearch in Google Scholar
Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020;2020.02.05.20020107. https://doi.org/10.1101/2020.02.05.20020107CaiGBulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCovmedRxiv20202020.02.05.20020107https://doi.org/10.1101/2020.02.05.20020107Open DOISearch in Google Scholar
Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021 Dec 02;600(7887):21. https://doi.org/10.1038/d41586-021-03552-wCallawayEHeavily mutated Omicron variant puts scientists on alertNature2021Dec 02600788721https://doi.org/10.1038/d41586-021-03552-w34824381Open DOISearch in Google Scholar
Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020 Dec;6(1):11. https://doi.org/10.1038/s41421-020-0147-1CaoYLiLFengZWanSHuangPSunXWenFHuangXNingGWangWComparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populationsCell Discov2020Dec6111https://doi.org/10.1038/s41421-020-0147-1704001132133153Open DOISearch in Google Scholar
CDC. How to Protect Yourself & Others [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2021 [cited 2022 Feb 20]. Available from https://www.cdc.gov/coronavirus/2019-ncov/prevent- getting-sick/ prevention.htmlCDC. How to Protect Yourself & Others [Internet]. Atlanta (USA): Centers for Disease Control and Prevention; 2021 [cited 2022 Feb 20]Available fromhttps://www.cdc.gov/coronavirus/2019-ncov/prevent- getting-sick/ prevention.htmlSearch in Google Scholar
Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, Yang Y, Liu B, Wang W, Wei C, et al. The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients. J Med Virol. 2020 Jul;92(7):833–840. https://doi.org/10.1002/jmv.25825ChenYChenLDengQZhangGWuKNiLYangYLiuBWangWWeiCet alThe presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patientsJ Med Virol2020Jul927833840https://doi.org/10.1002/jmv.2582532243607Open DOISearch in Google Scholar
Cheng Z, Zhou J, To KKW, Chu H, Li C, Wang D, Yang D, Zheng S, Hao K, Bossé Y, et al. Identification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenza. J Infect Dis. 2015 Oct 15;212(8):1214–1221. https://doi.org/10.1093/infdis/jiv246ChengZZhouJToKKWChuHLiCWangDYangDZhengSHaoKBosséYetalIdentification of TMPRSS2 as a susceptibility gene for severe 2009 pandemic A(H1N1) influenza and A(H7N9) influenzaJ Infect Dis2015Oct 15212812141221https://doi.org/10.1093/infdis/jiv246710739325904605Open DOISearch in Google Scholar
Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020 Jul;159(1):81–95. https://doi.org/10.1053/j.gastro.2020.03.065CheungKSHungIFNChanPPYLungKCTsoELiuRNgYYChuMYChungTWHTamARet alGastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysisGastroenterology2020Jul15918195https://doi.org/10.1053/j.gastro.2020.03.065719493632251668Open DOISearch in Google Scholar
Choi GJ, Baek SH, Kim J, Kim JH, Kwon GY, Kim DK, Jung YH, Kim S. Fatal systemic capillary leak syndrome after SARS-CoV-2 vaccination in patient with multiple myeloma. Emerg Infect Dis. 2021 Nov;27(11):2973–2975. https://doi.org/10.3201/eid2711.211723ChoiGJBaekSHKimJKimJHKwonGYKimDKJungYHKimSFatal systemic capillary leak syndrome after SARS-CoV-2 vaccination in patient with multiple myelomaEmerg Infect Dis2021Nov271129732975https://doi.org/10.3201/eid2711.211723854497734459725Open DOISearch in Google Scholar
Chua GT, Kwan MYW, Chui CSL, Smith RD, Cheung EC, Tian T, Leung MTY, Tsao SSL, Kan E, Ng WKC, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination. Clin Infect Dis. 2021 Nov 28:ciab989. https://doi.org/10.1093/cid/ciab989ChuaGTKwanMYWChuiCSLSmithRDCheungECTianTLeungMTYTsaoSSLKanENgWKCet alEpidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccinationClin Infect Dis2021Nov 28ciab989https://doi.org/10.1093/cid/ciab989876782334849657Open DOISearch in Google Scholar
Comirnaty, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 9]. Available from https://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdfComirnaty, Summary of product characteristics [Internet]Amsterdam (The Netherlands)European Medicines Agency;2022[cited 2022 Feb 9]. Available fromhttps://www.ema.europa.eu/en/documents/product-information/comirnaty-epar-product-information_en.pdfSearch in Google Scholar
Cornillez-Ty CT, Liao L, Yates JR 3rd, Kuhn P, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling. J Virol. 2009 Oct; 83(19):10314–10318. https://doi.org/10.1128/JVI.00842-09Cornillez-TyCTLiaoLYatesJR 3rdKuhnPBuchmeierMJSevere acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signalingJ Virol2009Oct83191031410318https://doi.org/10.1128/JVI.00842-09274802419640993Open DOISearch in Google Scholar
Correale P, Mutti L, Pentimalli F, Baglio G, Saladino RE, Sileri P, Giordano A. HLA-B*44 and C*01 prevalence correlates with covid19 spreading across Italy. Int J Mol Sci. 2020 Jul 23;21(15):5205. https://doi.org/10.3390/ijms21155205CorrealePMuttiLPentimalliFBaglioGSaladinoRESileriPGiordanoAHLA-B*44 and C*01 prevalence correlates with covid19 spreading across ItalyInt J Mol Sci2020Jul 2321155205https://doi.org/10.3390/ijms21155205743286032717807Open DOISearch in Google Scholar
COVID- 19 Vaccine AstraZeneca, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available from https://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-astrazeneca-product-information-approved-chmp-29-january-2021-pending-endorsement_en.pdfCOVID- 19 Vaccine AstraZeneca, Summary of product characteristics [Internet]Amsterdam (The Netherlands)European Medicines Agency2022[cited 2022 Feb 20]. Available fromhttps://www.ema.europa.eu/en/documents/product-information/covid-19-vaccine-astrazeneca-product-information-approved-chmp-29-january-2021-pending-endorsement_en.pdfSearch in Google Scholar
COVID-19 Vaccine AstraZeneca, Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/ vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdfCOVID-19 Vaccine AstraZeneca, Summary of product characteristicshttps://www.ema.europa.eu/en/documents/product-information/ vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-product-information_en.pdfSearch in Google Scholar
COVID-19 Vaccine Janssen, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available from https://www.ema.europa.eu/en/documents/product-information/jcovden-previously-covid-19-vaccine-janssen-epar-product-information_en.pdfCOVID-19 Vaccine Janssen, Summary of product characteristics [Internet]Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available fromhttps://www.ema.europa.eu/en/documents/product-information/jcovden-previously-covid-19-vaccine-janssen-epar-product-information_en.pdfSearch in Google Scholar
Davies JP, Almasy KM, McDonald EF, Plate L. Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus nonstructural proteins identifies unique and shared host-cell dependencies. ACS Infect Dis. 2020 Dec 11;6(12):3174–3189. https://doi.org/10.1021/acsinfecdis.0c00500DaviesJPAlmasyKMMcDonaldEFPlateLComparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus nonstructural proteins identifies unique and shared host-cell dependenciesACS Infect Dis2020Dec 1161231743189https://doi.org/10.1021/acsinfecdis.0c00500772476033263384Open DOISearch in Google Scholar
de Haan CAM, Vennema H, Rottier PJM. Assembly of the coronavirus envelope: homotypic interactions between the M proteins. J Virol. 2000 Jun;74(11):4967–4978. https://doi.org/10.1128/jvi.74.11.4967-4978.2000deHaan CAMVennemaHRottierPJMAssembly of the coronavirus envelope: homotypic interactions between the M proteinsJ Virol2000Jun741149674978https://doi.org/10.1128/jvi.74.11.4967-4978.200011084810799570Open DOISearch in Google Scholar
Du L, Zhao G, Lin Y, Chan C, He Y, Jiang S, Wu C, Jin DY, Yuen KY, Zhou Y, et al. Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Vaccine. 2008 Mar;26(13):1644–1651. https://doi.org/10.1016/j.vaccine.2008.01.025DuLZhaoGLinYChanCHeYJiangSWuCJinDYYuenKYZhouYet alPriming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infectionVaccine2008Mar261316441651https://doi.org/10.1016/j.vaccine.2008.01.025260087518289745Open DOISearch in Google Scholar
Duchene S, Featherstone L, Haritopoulou-Sinanidou M, Ram‑ baut A, Lemey P, Baele G. Temporal signal and the phylodynamic threshold of SARS-CoV-2. Virus Evol. 2020 Aug 19;6(2):veaa061. https://doi.org/10.1093/ve/veaa061DucheneSFeatherstoneLHaritopoulou-SinanidouMRam‑baut ALemeyPBaeleGTemporal signal and the phylodynamic threshold of SARS-CoV-2Virus Evol2020Aug 1962veaa061https://doi.org/10.1093/ve/veaa061745493633235813Open DOISearch in Google Scholar
ECDC. Options for the use of rapid antigen tests for COVID- 19 in the EU/EEA and the UK [Internet]. Stockholm (Sweden): European Centre for Disease Prevention and Control; 2020 [cited 2021 Apr 02]. Available from https://www.ecdc.europa.eu/sites/default/files/documents/Options-use-of-rapid-antigen-tests-for-COVID-19_0.pdfECDC. Options for the use of rapid antigen tests for COVID- 19 in the EU/EEA and the UK [Internet]Stockholm (Sweden)European Centre for Disease Prevention and Control;2020[cited 2021 Apr 02]. Available fromhttps://www.ecdc.europa.eu/sites/default/files/documents/Options-use-of-rapid-antigen-tests-for-COVID-19_0.pdfSearch in Google Scholar
Englisch CN, Tschernig T, Flockerzi F, Meier C, Bohle RM. Lesions in the lungs of fatal corona virus disease Covid- 19. Ann Anat. 2021 Mar;234:151657. https://doi.org/10.1016/j.aanat.2020.151657EnglischCNTschernigTFlockerziFMeierCBohleRMLesions in the lungs of fatal corona virus disease Covid- 19Ann Anat2021Mar234151657https://doi.org/10.1016/j.aanat.2020.151657771360233279630Open DOISearch in Google Scholar
Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DS, Mishra S, Crispim MAE, Sales FCS, Hawryluk I, McCrone JT, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021 May 21;372(6544):815–821. https://doi.org/10.1126/science.abh2644FariaNRMellanTAWhittakerCClaroIMCandidoDSMishraSCrispimMAESalesFCSHawrylukIMcCroneJTet alGenomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, BrazilScience2021May 213726544815821https://doi.org/10.1126/science.abh2644813942333853970Open DOISearch in Google Scholar
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. https://doi.org/10.1007/978-1-4939-2438-7_1FehrARPerlmanSCoronaviruses: an overview of their replication and pathogenesisMethods Mol Biol20151282123https://doi.org/10.1007/978-1-4939-2438-7_1436938525720466Open DOISearch in Google Scholar
Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV-2 variant: what we know and what we don’t. Anaesth Crit Care Pain Med. 2022 Feb;41(1):100998. https://doi.org/10.1016/j.accpm.2021.100998FerréVMPeiffer-SmadjaNVisseauxBDescampsDGhosnJCharpentierCOmicron SARS-CoV-2 variant: what we know and what we don’tAnaesth Crit Care Pain Med2022Feb411100998https://doi.org/10.1016/j.accpm.2021.100998866066034902630Open DOISearch in Google Scholar
Flisiak R, Horban A, Jaroszewicz J, Kozielewicz D, Pawłowska M, Parczewski M, Piekarska A, Simon K, Tomasiewicz K, Zarębska-Michaluk D. [Zalecenia postępowania w zakażeniach SARS-CoV-2 Polskiego Towarzystwa Epidemiologów i Lekarzy Chorób Zakaźnych, na dzień 26 kwietnia 2021] (in Polish) [Internet]. PTEiLChZ 30.04.2021 [cited 2022 Feb 04]. Available from https://www.mp.pl/covid19/zalecenia/265853,zalecenia-postepowania-w-zakazeniach-sars-cov-2-polskiego-towarzystwa-epidemiologow-i-lekarzy-chorob-zakaznych-26042021FlisiakRHorbanAJaroszewiczJKozielewiczDPawłowskaMParczewskiMPiekarskaASimonKTomasiewiczKZarębska-MichalukD[Zalecenia postępowania w zakażeniach SARS-CoV-2 Polskiego Towarzystwa Epidemiologów i Lekarzy Chorób Zakaźnych, na dzień 26 kwietnia 2021] (in Polish) [Internet]PTEiLChZ 30.04.2021 [cited 2022 Feb 04]Available fromhttps://www.mp.pl/covid19/zalecenia/265853,zalecenia-postepowania-w-zakazeniach-sars-cov-2-polskiego-towarzystwa-epidemiologow-i-lekarzy-chorob-zakaznych-26042021Search in Google Scholar
Franchini M, Liumbruno GM, Pezzo M. COVID‐19 vaccine‐ associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021 Aug;107(2):173–180. https://doi.org/10.1111/ejh.13665FranchiniMLiumbrunoGMPezzoMCOVID‐19 vaccine‐ associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndromeEur J Haematol2021Aug1072173180https://doi.org/10.1111/ejh.13665823951633987882Open DOISearch in Google Scholar
Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC, Zingaropoli MA, et al. Chest CT score in COVID- 19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020 Dec;30(12): 6808–6817. https://doi.org/10.1007/s00330-020-07033-yFranconeMIafrateFMasciGMCocoSCiliaFManganaroLPanebiancoVAndreoliCColaiacomoMCZingaropoliMAet alChest CT score in COVID- 19 patients: correlation with disease severity and short-term prognosisEur Radiol2020Dec301268086817https://doi.org/10.1007/s00330-020-07033-y733462732623505Open DOISearch in Google Scholar
Gao G, Guo X, Goff SP. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science. 2002 Sep 06; 297(5587):1703–1706. https://doi.org/10.1126/science.1074276GaoGGuoXGoffSPInhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger proteinScience2002Sep 06297558717031706https://doi.org/10.1126/science.107427612215647Open DOISearch in Google Scholar
Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, Broder KR, Gee J, Weintraub E, Shimabukuro T, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 09;70(27):977–982. https://doi.org/10.15585/mmwr.mm7027e2GarganoJWWallaceMHadlerSCLangleyGSuJROsterMEBroderKRGeeJWeintraubEShimabukuroTet alUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices – United States, June 2021MMWR Morb Mortal Wkly Rep2021Jul 097027977982https://doi.org/10.15585/mmwr.mm7027e2831275434237049Open DOISearch in Google Scholar
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Monte‑ jano R, Spinner CD, Galli M, Ahn MY, Nahass RG, et al.; GS-US-540-5773 Investigators. Remdesivir for 5 or 10 days in patients with severe Covid- 19. N Engl J Med. 2020 Nov 05;383(19):1827–1837. https://doi.org/10.1056/nejmoa2015301GoldmanJDLyeDCBHuiDSMarksKMBrunoRMonte‑jano RSpinnerCDGalliMAhnMYNahassRGet alGS-US-540-5773 Investigators. Remdesivir for 5 or 10 days in patients with severe Covid- 19N Engl J Med2020Nov 053831918271837https://doi.org/10.1056/nejmoa2015301Open DOISearch in Google Scholar
Grams SE, Moonsamy PV, Mano C, Oksenberg JR, Begovich AB. Two new HLA-B alleles, B*4422 and B*4704, identified in a study of families with autoimmunity. Tissue Antigens. 2002 Apr;59(4):338–340. https://doi.org/10.1034/j.1399-0039.2002.590417.xGramsSEMoonsamyPVManoCOksenbergJRBegovichABTwo new HLA-B alleles, B*4422 and B*4704, identified in a study of families with autoimmunityTissue Antigens2002Apr594338340https://doi.org/10.1034/j.1399-0039.2002.590417.x12135438Open DOISearch in Google Scholar
Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020 Jul 28;71(15):778–785. https://doi.org/10.1093/cid/ciaa310GuoLRenLYangSXiaoMChangDYangFDelaCruz CSWangYWuCXiaoYet alProfiling early humoral response to diagnose novel coronavirus disease (COVID-19)Clin Infect Dis2020Jul 287115778785https://doi.org/10.1093/cid/ciaa310718447232198501Open DOISearch in Google Scholar
Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, et al.; STOP-COVID Investigators. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020 Nov 01;180(11):1436–1447. https://doi.org/10.1001/jamainternmed.2020.3596GuptaSHayekSSWangWChanLMathewsKSMelamedMLBrennerSKLeonberg-YooASchenckEJRadbelJet alSTOP-COVID Investigators. Factors associated with death in critically ill patients with coronavirus disease 2019 in the USJAMA Intern Med2020Nov 011801114361447https://doi.org/10.1001/jamainternmed.2020.3596736433832667668Open DOISearch in Google Scholar
Hachim MY, Al Heialy S, Hachim IY, Halwani R, Senok AC, Maghazachi AA, Hamid Q. Interferon-induced transmembrane protein (IFITM3) is upregulated explicitly in SARS-CoV-2 infected lung epithelial cells. Front Immunol. 2020 Jun 10;11:1372. https://doi.org/10.3389/fimmu.2020.01372HachimMYAlHeialy SHachimIYHalwaniRSenokACMaghazachiAAHamidQInterferon-induced transmembrane protein (IFITM3) is upregulated explicitly in SARS-CoV-2 infected lung epithelial cellsFront Immunol2020Jun 10111372https://doi.org/10.3389/fimmu.2020.01372730188632595654Open DOISearch in Google Scholar
Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, Peacock SJ, et al.; COVID-19 Genomics UK (COG-UK) Consortium. SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021 Jul; 19(7):409–424. https://doi.org/10.1038/s41579-021-00573-0HarveyWTCarabelliAMJacksonBGuptaRKThomsonECHarrisonEMLuddenCReeveRRambautAPeacockSJet alCOVID-19 Genomics UK (COG-UK) ConsortiumSARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol2021Jul197409424https://doi.org/10.1038/s41579-021-00573-0816783434075212Open DOISearch in Google Scholar
Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pöhlmann S. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2014 Jan 15;88(2):1293–1307. https://doi.org/10.1128/JVI.02202-13HeurichAHofmann-WinklerHGiererSLiepoldTJahnOPöhlmannSTMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike proteinJ Virol2014Jan 1588212931307https://doi.org/10.1128/JVI.02202-13Open DOISearch in Google Scholar
Hirotsu Y, Maejima M, Shibusawa M, Nagakubo Y, Hosaka K, Amemiya K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, et al. Comparison of automated SARS-CoV-2 antigen test for COVID- 19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. Int J Infect Dis. 2020 Oct;99:397–402. https://doi.org/10.1016/j.ijid.2020.08.029HirotsuYMaejimaMShibusawaMNagakuboYHosakaKAmemiyaKSuekiHHayakawaMMochizukiHTsutsuiTet alComparison of automated SARS-CoV-2 antigen test for COVID- 19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patientsInt J Infect Dis2020Oct99397402https://doi.org/10.1016/j.ijid.2020.08.029Open DOISearch in Google Scholar
Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020 May21;78(4):779–784.e5. https://doi.org/10.1016/j.molcel.2020.04.022HoffmannMKleine-WeberHPöhlmannSA multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cellsMol Cell2020May21784779784.e5https://doi.org/10.1016/j.molcel.2020.04.022Open DOISearch in Google Scholar
Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, et al.; RECOV‑ ERY Collaborative Group. Effect of Hydroxychloroquine in Hospitalized Patients with Covid- 19. N Engl J Med. 2020 Nov 19; 383(21): 2030–2040. https://doi.org/10.1056/NEJMoa2022926HorbyPMafhamMLinsellLBellJLStaplinNEmbersonJRWiselkaMUstianowskiAElmahiEPrudonBet alRECOV‑ ERY Collaborative GroupEffect of Hydroxychloroquine in Hospitalized Patients with Covid- 19. N Engl J Med2020Nov 193832120302040https://doi.org/10.1056/NEJMoa2022926Open DOISearch in Google Scholar
Hu B, Zeng LP, Yang XL, Ge XY, Zhang W, Li B, Xie JZ, Shen XR, Zhang YZ, Wang N, et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS Pathog. 2017 Nov 30;13(11):e1006698. https://doi.org/10.1371/journal.ppat.1006698HuBZengLPYangXLGeXYZhangWLiBXieJZShenXRZhangYZWangNet alDiscovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirusPLoS Pathog2017Nov 301311e1006698https://doi.org/10.1371/journal.ppat.1006698Open DOISearch in Google Scholar
Huang Y, Yang C, Xu Xf, Xu W, Liu Sw. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID- 19. Acta Pharmacol Sin. 2020 Sep; 41(9): 1141–1149. https://doi.org/10.1038/s41401-020-0485-4HuangYYangCXuXfXuWLiuSwStructural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID- 19Acta Pharmacol Sin2020Sep41911411149https://doi.org/10.1038/s41401-020-0485-4Open DOISearch in Google Scholar
Hussain M, Jabeen N, Raza F, Shabbir S, Baig AA, Amanullah A, Aziz B. Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein. J Med Virol. 2020 Sep; 92(9):1580–1586. https://doi.org/10.1002/jmv.25832HussainMJabeenNRazaFShabbirSBaigAAAmanullahAAzizBStructural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike proteinJ Med Virol2020Sep92915801586https://doi.org/10.1002/jmv.25832Open DOISearch in Google Scholar
Jung ES, Cheon JH, Lee JH, Park SJ, Jang HW, Chung SH, Park MH, Kim TG, Oh HB, Yang SK, et al. HLA-C*01 is a risk factor for Crohn’s disease. Inflamm Bowel Dis. 2016 Apr;22(4):796–806. https://doi.org/10.1097/MIB.0000000000000693JungESCheonJHLeeJHParkSJJangHWChungSHParkMHKimTGOhHBYangSKet alHLA-C*01 is a risk factor for Crohn’s diseaseInflamm Bowel Dis2016Apr224796806https://doi.org/10.1097/MIB.0000000000000693Open DOISearch in Google Scholar
Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID- 19 pandemic. Lancet. 2021 Dec 11;398(10317): 2126–2128. https://doi.org/10.1016/S0140-6736(21)02758-6KarimSSAKarimQAOmicron SARS-CoV-2 variant: a new chapter in the COVID- 19 pandemicLancet2021Dec 113981031721262128https://doi.org/10.1016/S0140-6736(21)02758-6Open DOISearch in Google Scholar
Kashour Z, Riaz M, Garbati MA, AlDosary O, Tlayjeh H, Ger‑ beri D, Murad MH, Sohail MR, Kashour T, Tleyjeh IM. Efficacy of chloroquine or hydroxychloroquine in COVID- 19 patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2021 Jan 01;76(1):30–42. https://doi.org/10.1093/jac/dkaa403KashourZRiazMGarbatiMAAlDosaryOTlayjehHGer‑beri DMuradMHSohailMRKashourTTleyjehIMEfficacy of chloroquine or hydroxychloroquine in COVID- 19 patients: a systematic review and meta-analysisJ Antimicrob Chemother2021Jan 017613042https://doi.org/10.1093/jac/dkaa403766554333031488Open DOISearch in Google Scholar
Kim D, Lee JY, Yang JS, Kim JW, Kim VN, Chang H. The architecture of SARS-CoV-2 transcriptome. Cell. 2020 May; 181(4):914–921.e10. https://doi.org/10.1016/j.cell.2020.04.011KimDLeeJYYangJSKimJWKimVNChangHThe architecture of SARS-CoV-2 transcriptomeCell2020May1814914921e10https://doi.org/10.1016/j.cell.2020.04.011Open DOISearch in Google Scholar
Koçak Tufan Z, Kayaaslan B, Mer M. COVID- 19 and sepsis. Turk J Med Sci. 2021 Dec 17;51 SI-1:3301–3311. https://doi.org/10.3906/sag-2108-239KoçakTufan ZKayaaslanBMerMCOVID- 19 and sepsisTurk J Med Sci2021Dec 17;51 SI-133013311https://doi.org/10.3906/sag-2108-239Open DOISearch in Google Scholar
Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein. J Med Virol. 2022 Apr;94(4):1641–1649. https://doi.org/10.1002/jmv.27526KumarSThambirajaTSKaruppananKSubramaniamGOmicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike proteinJ Med Virol2022Apr94416411649https://doi.org/10.1002/jmv.27526Open DOISearch in Google Scholar
Lagevrio, Summary of Product Characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 15]. Available from https://www.ema.europa.eu/en/documents/referral/lagevrio-also-known-molnupiravir-mk-4482-covid-19-article-53-procedure-conditions-use-conditions_en.pdfLagevrio, Summary of Product Characteristics [Internet]Amsterdam (The Netherlands)European Medicines Agency;2022[cited 2022 Feb 15]. Available fromhttps://www.ema.europa.eu/en/documents/referral/lagevrio-also-known-molnupiravir-mk-4482-covid-19-article-53-procedure-conditions-use-conditions_en.pdfSearch in Google Scholar
Lan SH, Lai CC, Huang HT, Chang SP, Lu LC, Hsueh PR. Tocilizumab for severe COVID- 19: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020 Sep;56(3):106103. https://doi.org/10.1016/j.ijantimicag.2020.106103LanSHLaiCCHuangHTChangSPLuLCHsuehPRTocilizumab for severe COVID- 19: a systematic review and meta-analysisInt J Antimicrob Agents2020Sep563106103https://doi.org/10.1016/j.ijantimicag.2020.106103Open DOISearch in Google Scholar
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of corona-virus disease 2019 (CoVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020 May 05; 172(9):577–582. https://doi.org/10.7326/M20-0504LauerSAGrantzKHBiQJonesFKZhengQMeredithHRAzmanASReichNGLesslerJThe incubation period of corona-virus disease 2019 (CoVID-19) from publicly reported confirmed cases: estimation and applicationAnn Intern Med2020May 051729577582https://doi.org/10.7326/M20-0504Open DOISearch in Google Scholar
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251–2261. https://doi.org/10.1007/s00405-020-05965-1LechienJRChiesa-EstombaCMDe SiatiDRHoroiMLe BonSDRodriguezADequanterDBlecicSElAfia FDistinguinLet alOlfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European studyEur Arch Otorhinolaryngol2020Aug277822512261https://doi.org/10.1007/s00405-020-05965-1Open DOISearch in Google Scholar
Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. Antiviral Res. 2018 Jan; 149:58–74. https://doi.org/10.1016/j.antiviral.2017.11.001LeiJKusovYHilgenfeldRNsp3 of coronaviruses: Structures and functions of a large multi-domain proteinAntiviral Res2018Jan1495874https://doi.org/10.1016/j.antiviral.2017.11.001Open DOISearch in Google Scholar
Lescure FX, Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, Gaymard A, Bouscambert-Duchamp M, Donati F, Le Hingrat Q, et al. Clinical and virological data of the first cases of COVID- 19 in Europe: a case series. Lancet Infect Dis. 2020 Jun; 20(6):697–706. https://doi.org/10.1016/S1473-3099(20)30200-0LescureFXBouadmaLNguyenDPariseyMWickyPHBehillilSGaymardABouscambert-DuchampMDonatiFLe HingratQet alClinical and virological data of the first cases of COVID- 19 in Europe: a case seriesLancet Infect Dis2020Jun206697706https://doi.org/10.1016/S1473-3099(20)30200-0Open DOISearch in Google Scholar
Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016 Sep 29;3(1):237–261. https://doi.org/10.1146/annurev-virology-110615-042301LiFStructure, function, and evolution of coronavirus spike proteinsAnnu Rev Virol2016Sep 2931237261https://doi.org/10.1146/annurev-virology-110615-042301545796227578435Open DOISearch in Google Scholar
Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, Ding S, He Y, Liang C, Lee JC, et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 2013 Jan;9(1):e1003124. https://doi.org/10.1371/journal.ppat.1003124LiKMarkosyanRMZhengYMGolfettoOBungartBLiMDingSHeYLiangCLeeJCet alIFITM proteins restrict viral membrane hemifusionPLoS Pathog2013Jan91e1003124https://doi.org/10.1371/journal.ppat.1003124355458323358889Open DOISearch in Google Scholar
Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020a Dec;9(1):45. https://doi.org/10.1186/s40249-020-00662-xLiMYLiLZhangYWangXSExpression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissuesInfect Dis Poverty2020aDec9145https://doi.org/10.1186/s40249-020-00662-xOpen DOISearch in Google Scholar
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020b Apr;10(2): 102–108. https://doi.org/10.1016/j.jpha.2020.03.001LiXGengMPengYMengLLuSMolecular immune pathogenesis and diagnosis of COVID-19J Pharm Anal2020bApr102102108https://doi.org/10.1016/j.jpha.2020.03.001Open DOISearch in Google Scholar
Lim Y, Ng Y, Tam J, Liu D. Human Coronaviruses: A Review of Virus-Host Interactions. Diseases. 2016 Jul 25;4(4):26. https://doi.org/10.3390/diseases4030026LimYNgYTamJLiuDHuman Coronaviruses: A Review of Virus-Host InteractionsDiseases2016Jul 254426https://doi.org/10.3390/diseases4030026Open DOISearch in Google Scholar
Lin L, Liu Y, Tang X, He D. The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front Public Health. 2021 Nov 30;9:775224. https://doi.org/10.3389/fpubh.2021.775224LinLLiuYTangXHeDThe disease severity and clinical outcomes of the SARS-CoV-2 variants of concernFront Public Health2021Nov 309775224https://doi.org/10.3389/fpubh.2021.775224Open DOISearch in Google Scholar
Lisboa Bastos M, Tavaziva G, Abidi SK, Campbell JR, Haraoui LP, Johnston JC, Lan Z, Law S, MacLean E, Trajman A, et al. Diagnostic accuracy of serological tests for covid- 19: systematic review and meta-analysis. BMJ. 2020 Jul 01;370:m2516. https://doi.org/10.1136/bmj.m2516LisboaBastos MTavazivaGAbidiSKCampbellJRHaraouiLPJohnstonJCLanZLawSMacLeanETrajmanAet alDiagnostic accuracy of serological tests for covid- 19: systematic review and meta-analysisBMJ2020Jul 01370m2516https://doi.org/10.1136/bmj.m2516Open DOISearch in Google Scholar
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, et al.; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021 Feb; 397(10275):671–681. https://doi.org/10.1016/S0140-6736(21)00234-8LogunovDYDolzhikovaIVShcheblyakovDVTukhvatulinAIZubkovaOVDzharullaevaASKovyrshinaAVLubenetsNLGrousovaDMErokhovaASet alGam-COVID-Vac Vaccine Trial GroupSafety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet2021Feb39710275671681https://doi.org/10.1016/S0140-6736(21)00234-8Open DOISearch in Google Scholar
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb;395(10224):565–574. https://doi.org/10.1016/S0140-6736(20)30251-8LuRZhaoXLiJNiuPYangBWuHWangWSongHHuangBZhuNet alGenomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingLancet2020Feb39510224565574https://doi.org/10.1016/S0140-6736(20)30251-8Open DOISearch in Google Scholar
Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020 May; 526(1):165–169. https://doi.org/10.1016/j.bbrc.2020.03.047LuanJLuYJinXZhangLSpike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infectionBiochem Biophys Res Commun2020May5261165169https://doi.org/10.1016/j.bbrc.2020.03.047710251532201080Open DOISearch in Google Scholar
Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ. A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19. Future Virol. 2021 Nov:10.2217/fvl-2021-0211. https://doi.org/10.2217/fvl-2021-0211MakoahNATipihTLitabeMMBrinkMSempaJBGoedhalsDBurtFJA systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19Future Virol2021Nov:10.2217/fvl-2021-0211https://doi.org/10.2217/fvl-2021-0211868684134950219Open DOISearch in Google Scholar
Malik JA, Ahmed S, Mir A, Shinde M, Bender O, Alshammari F, Ansari M, Anwar S. The SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challenges. J Infect Public Health. 2022 Feb;15(2):228–240. https://doi.org/10.1016/j.jiph.2021.12.014MalikJAAhmedSMirAShindeMBenderOAlshammariFAnsariMAnwarSThe SARS-CoV-2 mutations versus vaccine effectiveness: new opportunities to new challengesJ Infect Public Health2022Feb152228240https://doi.org/10.1016/j.jiph.2021.12.014873067435042059Open DOISearch in Google Scholar
Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H. Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein. PLoS Pathog. 2013 Jul 11;9(7):e1003494. https://doi.org/10.1371/journal.ppat.1003494MaoRNieHCaiDZhangJLiuHYanRCuconatiABlockTMGuoJTGuoHInhibition of hepatitis B virus replication by the host zinc finger antiviral proteinPLoS Pathog2013Jul 1197e1003494https://doi.org/10.1371/journal.ppat.1003494370888723853601Open DOISearch in Google Scholar
McBride R, van Zyl M, Fielding B. The coronavirus nucleocapsid is a multifunctional protein. Viruses. 2014 Aug 07;6(8):2991–3018. https://doi.org/10.3390/v6082991McBrideRvanZyl MFieldingBThe coronavirus nucleocapsid is a multifunctional proteinViruses2014Aug 076829913018https://doi.org/10.3390/v6082991414768425105276Open DOISearch in Google Scholar
McDonald I, Murray SM, Reynolds CJ, Altmann DM, Boyton RJ. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. npj Vaccines. 2021 Dec;6(1):74. https://doi.org/10.1038/s41541-021-00336-1McDonaldIMurraySMReynoldsCJAltmannDMBoytonRJComparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2npj Vaccines2021Dec6174https://doi.org/10.1038/s41541-021-00336-1811664533986272Open DOISearch in Google Scholar
McFadyen JD, Stevens H, Peter K. The emerging threat of (micro) thrombosis in COVID- 19 and its therapeutic implications. Circ Res. 2020 Jul 31;127(4):571–587. https://doi.org/10.1161/CIRCRESAHA.120.317447McFadyenJDStevensHPeterKThe emerging threat of (micro) thrombosis in COVID- 19 and its therapeutic implicationsCirc Res2020Jul 311274571587https://doi.org/10.1161/CIRCRESAHA.120.317447738687532586214Open DOISearch in Google Scholar
Meagher JL, Takata M, Gonçalves-Carneiro D, Keane SC, Rebendenne A, Ong H, Orr VK, MacDonald MR, Stuckey JA, Bieniasz PD, et al. Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences. Proc Natl Acad Sci USA. 2019 Nov 26; 116(48):24303–24309. https://doi.org/10.1073/pnas.1913232116MeagherJLTakataMGonçalves-CarneiroDKeaneSCRebendenneAOngHOrrVKMacDonaldMRStuckeyJABieniaszPDet alStructure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequencesProc Natl Acad Sci USA2019Nov 26116482430324309https://doi.org/10.1073/pnas.1913232116688378431719195Open DOISearch in Google Scholar
Mustafa Hellou M, Górska A, Mazzaferri F, Cremonini E, Gentilotti E, De Nardo P, Poran I, Leeflang MM, Tacconelli E, Paul M. Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2021 Mar;27(3):341–351. https://doi.org/10.1016/j.cmi.2020.11.002MustafaHellou MGórskaAMazzaferriFCremoniniEGentilottiEDeNardo PPoranILeeflangMMTacconelliEPaulMNucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysisClin Microbiol Infect2021Mar273341351https://doi.org/10.1016/j.cmi.2020.11.002765761433188933Open DOISearch in Google Scholar
Nasreen S, Chung H, He S, Brown KA, Gubbay JB, Buchan SA, Fell DB, Austin PC, Schwartz KL, Sundaram ME, et al.; Canadian Immunization Research Network (CIRN) Provincial Collabora‑ tive Network (PCN) Investigators. Effectiveness of COVID- 19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat Microbiol. 2022 Mar;7(3):379–385. https://doi.org/10.1038/s41564-021-01053-0NasreenSChungHHeSBrownKAGubbayJBBuchanSAFellDBAustinPCSchwartzKLSundaramMEet alCanadian Immunization Research Network (CIRN) Provincial Collabora‑ tive Network (PCN) InvestigatorsEffectiveness of COVID- 19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat Microbiol2022Mar73379385https://doi.org/10.1038/s41564-021-01053-035132198Open DOISearch in Google Scholar
Nguyen A, David JK, Maden SK, Wood MA, Weeder BR, Nel‑ lore A, Thompson RF. Human leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2. J Virol. 2020 Jun 16;94(13):e00510-20. https://doi.org/10.1128/JVI.00510-20NguyenADavidJKMadenSKWoodMAWeederBRNel‑lore AThompsonRFHuman leukocyte antigen susceptibility map for severe acute respiratory syndrome coronavirus 2J Virol2020Jun 169413e0051020https://doi.org/10.1128/JVI.00510-20730714932303592Open DOISearch in Google Scholar
Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, Jimenez-Guardeño JM, Regla-Nava JA, Fernandez-Delgado R, Castaño-Rodriguez C, Alcaraz A, Torres J, Aguilella VM, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014 May 1;10(5):e1004077. https://doi.org/10.1371/journal.ppat.1004077Nieto-TorresJLDeDiegoMLVerdiá-BáguenaCJimenez-GuardeñoJMRegla-NavaJAFernandez-DelgadoRCastaño-RodriguezCAlcarazATorresJAguilellaVMet alSevere acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesisPLoS Pathog2014May 1105e1004077https://doi.org/10.1371/journal.ppat.1004077400687724788150Open DOISearch in Google Scholar
O’Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, et al; Covid-19 Phase 3 Prevention Trial Team. Subcutaneous REGEN-COV antibody combination to prevent COVID-19. N Engl J Med. 2021 Sep 23;385(13):1184–1195. https://doi.org10.1056/NEJMoa2109682O’BrienMPForleo-NetoEMusserBJIsaFChanKCSarkarNBarKJBarnabasRVBarouchDHCohenMSetal; Covid-19 Phase 3 Prevention Trial TeamSubcutaneous REGEN-COV antibody combination to prevent COVID-19N Engl J Med2021Sep 23385131184119510.1056/NEJMoa210968210.1056/NEJMoa2109682836259334347950Search in Google Scholar
Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). How to interpret and use COVID- 19 serology and immunology tests. Clin Microbiol Infect. 2021 Jul;27(7):981–986. https://doi.org/10.1016/j.cmi.2021.05.001OngDSYFragkouPCSchweitzerVAChemalyRFMoschopoulosCDSkevakiC; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV)How to interpret and use COVID- 19 serology and immunology testsClin Microbiol Infect2021Jul277981986https://doi.org/10.1016/j.cmi.2021.05.001810652233975005Open DOISearch in Google Scholar
Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020 Mar 27;11(1):1620. https://doi.org/10.1038/s41467-020-15562-9OuXLiuYLeiXLiPMiDRenLGuoLGuoRChenTHuJet alCharacterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVNat Commun2020Mar 271111620https://doi.org/10.1038/s41467-020-15562-9710051532221306Open DOISearch in Google Scholar
Padoan A, Sciacovelli L, Basso D, Negrini D, Zuin S, Cosma C, Faggian D, Matricardi P, Plebani M. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study. Clin Chim Acta. 2020 Aug;507:164–166. https://doi.org/10.1016/j.cca.2020.04.026PadoanASciacovelliLBassoDNegriniDZuinSCosmaCFaggianDMatricardiPPlebaniMIgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal studyClin Chim Acta2020Aug507164166https://doi.org/10.1016/j.cca.2020.04.026719488632343948Open DOISearch in Google Scholar
Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B, et al. SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol. 2020 Sep; 92(9):1676–1680. https://doi.org/10.1002/jmv.25936PengLLiuJXuWLuoQChenDLeiZHuangZLiXDengKLinBet alSARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimensJ Med Virol2020Sep92916761680https://doi.org/10.1002/jmv.25936726452132330305Open DOISearch in Google Scholar
Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009 Jun;7(6):439–450. https://doi.org/10.1038/nrmicro2147PerlmanSNetlandJCoronaviruses post-SARS: update on replication and pathogenesisNat Rev Microbiol2009Jun76439450https://doi.org/10.1038/nrmicro2147283009519430490Open DOISearch in Google Scholar
Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID- 19: systematic review and meta-analysis. Thromb Res. 2020 Dec; 196:67–74. https://doi.org/10.1016/j.thromres.2020.08.020PorfidiaAValerianiEPolaRPorrecaERutjesAWSDiNisio MVenous thromboembolism in patients with COVID- 19: systematic review and meta-analysisThromb Res2020Dec1966774https://doi.org/10.1016/j.thromres.2020.08.020742098232853978Open DOISearch in Google Scholar
Pulliam JRC, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, Dushoff J, Mlisana K, Moultrie H. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv. 2021; 2021.11.11.21266068. https://doi.org/10.1101/2021.11.11.21266068PulliamJRCvanSchalkwyk CGovenderNvonGottberg ACohenCGroomeMJDushoffJMlisanaKMoultrieHIncreased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South AfricamedRxiv20212021.11.11.21266068https://doi.org/10.1101/2021.11.11.21266068Open DOISearch in Google Scholar
Pyrc K, Dijkman R, Deng L, Jebbink MF, Ross HA, Berkhout B, van der Hoek L. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol. 2006 Dec;364(5):964–973. https://doi.org/10.1016/j.jmb.2006.09.074PyrcKDijkmanRDengLJebbinkMFRossHABerkhoutBvander Hoek LMosaic structure of human coronavirus NL63, one thousand years of evolutionJ Mol Biol2006Dec3645964973https://doi.org/10.1016/j.jmb.2006.09.074709470617054987Open DOISearch in Google Scholar
Ramanathan K, Shekar K, Ling RR, Barbaro RP, Wong SN, Tan CS, Rochwerg B, Fernando SM, Takeda S, MacLaren G, et al. Extracorporeal membrane oxygenation for COVID- 19: a systematic review and meta-analysis. Crit Care. 2021 Dec;25(1):211. https://doi.org/10.1186/s13054-021-03634-1RamanathanKShekarKLingRRBarbaroRPWongSNTanCSRochwergBFernandoSMTakedaSMacLarenGet alExtracorporeal membrane oxygenation for COVID- 19: a systematic review and meta-analysisCrit Care2021Dec251211https://doi.org/10.1186/s13054-021-03634-1820144034127027Open DOISearch in Google Scholar
Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock T, Robertson D, Volz E. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations [Internet]. 2020 [cited 2022 Feb 04]. Available from https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563RambautALomanNPybusOBarclayWBarrettJCarabelliAConnorTPeacockTRobertsonDVolzEPreliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations [Internet]2020[cited 2022 Feb 04]. Available fromhttps://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563Search in Google Scholar
Ravi N, Cortade DL, Ng E, Wang SX. Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID- 19 testing landscape. Biosens Bioelectron. 2020 Oct;165:112454. https://doi.org/10.1016/j.bios.2020.112454RaviNCortadeDLNgEWangSXDiagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID- 19 testing landscapeBiosens Bioelectron2020Oct165112454https://doi.org/10.1016/j.bios.2020.112454736866332729549Open DOISearch in Google Scholar
Ravindra K, Malik VS, Padhi BK, Goel S, Gupta M. Asymptomatic infection and transmission of COVID-19 among clusters: systematic review and meta-analysis. Public Health. 2022 Feb;203:100–109. https://doi.org/10.1016/j.puhe.2021.12.003RavindraKMalikVSPadhiBKGoelSGuptaMAsymptomatic infection and transmission of COVID-19 among clusters: systematic review and meta-analysisPublic Health2022Feb203100109https://doi.org/10.1016/j.puhe.2021.12.003865459735038628Open DOISearch in Google Scholar
RoActemra, Summary of product characteristics[Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 15]. Available from https://www.ema.europa.eu/en/documents/product-information/roactemra-epar-product-information_en.pdfRoActemra, Summary of product characteristics[Internet]Amsterdam (The Netherlands)European Medicines Agency;2022[cited 2022 Feb 15]. Available fromhttps://www.ema.europa.eu/en/documents/product-information/roactemra-epar-product-information_en.pdfSearch in Google Scholar
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, et al.; ENSEMBLE Study Group. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021 Jun 10;384(23):2187–2201. https://doi.org/10.1056/NEJMoa2101544SadoffJGrayGVandeboschACárdenasVShukarevGGrinsztejnBGoepfertPATruyersCFennemaHSpiessensBet alENSEMBLE Study GroupSafety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med2021Jun 103842321872201https://doi.org/10.1056/NEJMoa2101544822099633882225Open DOISearch in Google Scholar
Sakai Y, Kawachi K, Terada Y, Omori H, Matsuura Y, Kamitani W. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication. Virology. 2017 Oct;510:165–174. https://doi.org/10.1016/j.virol.2017.07.019SakaiYKawachiKTeradaYOmoriHMatsuuraYKamitaniWTwo-amino acids change in the nsp4 of SARS coronavirus abolishes viral replicationVirology2017Oct510165174https://doi.org/10.1016/j.virol.2017.07.019711169528738245Open DOISearch in Google Scholar
Santos JC, Passos GA. The high infectivity of SARS-CoV-2 B. 1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation. bioRxiv. 2020; 2020.12.29. 424708. https://doi.org/10.1101/2020.12.29.424708SantosJCPassosGAThe high infectivity of SARS-CoV-2 B. 1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutationbioRxiv20202020.12.29. 424708https://doi.org/10.1101/2020.12.29.424708Open DOISearch in Google Scholar
Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, Gurzeler LA, Leibundgut M, Thiel V, Mühlemann O, Ban N. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. 2020 Oct;27(10):959–966. https://doi.org/10.1038/s41594-020-0511-8SchubertKKarousisEDJomaaAScaiolaAEcheverriaBGurzelerLALeibundgutMThielVMühlemannOBanNSARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translationNat Struct Mol Biol2020Oct2710959966https://doi.org/10.1038/s41594-020-0511-832908316Open DOISearch in Google Scholar
Severe Covid- 19 GWAS Group; Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, et al. Genomewide association study of severe COVID- 19 with respiratory failure. N Engl J Med. 2020 Oct 15; 383(16):1522–1534. https://doi.org/10.1056/NEJMoa2020283SevereCovid- 19 GWAS Group; Ellinghaus DDegenhardtFBujandaLButiMAlbillosAInvernizziPFernándezJPratiDBaselliGAsseltaRetalGenomewide association study of severe COVID- 19 with respiratory failureN Engl J Med2020Oct 153831615221534https://doi.org/10.1056/NEJMoa2020283731589032558485Open DOISearch in Google Scholar
Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, Li F. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020 May 26;117(21):11727–11734. https://doi.org/10.1073/pnas.2003138117ShangJWanYLuoCYeGGengQAuerbachALiFCell entry mechanisms of SARS-CoV-2Proc Natl Acad Sci USA2020May 26117211172711734https://doi.org/10.1073/pnas.2003138117726097532376634Open DOISearch in Google Scholar
Sharma S, Patnaik SK, Thomas Taggart R, Kannisto ED, Enriquez SM, Gollnick P, Baysal BE. APOBEC3A cytidine deam-inase induces RNA editing in monocytes and macrophages. Nat Commun. 2015 Nov;6(1):6881. https://doi.org/10.1038/ncomms7881SharmaSPatnaikSKThomasTaggart RKannistoEDEnriquezSMGollnickPBaysalBEAPOBEC3A cytidine deam-inase induces RNA editing in monocytes and macrophagesNat Commun2015Nov616881https://doi.org/10.1038/ncomms7881441129725898173Open DOISearch in Google Scholar
Singh AK, Singh A, Singh R, Misra A. Molnupiravir in COVID- 19: A systematic review of literature. Diabetes Metab Syndr. 2021 Nov; 15(6):102329. https://doi.org/10.1016/j.dsx.2021.102329SinghAKSinghASinghRMisraAMolnupiravir in COVID- 19: A systematic review of literatureDiabetes Metab Syndr2021Nov156102329https://doi.org/10.1016/j.dsx.2021.102329855668434742052Open DOISearch in Google Scholar
Singh Tomar PP, Arkin IT. SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine. Biochem Biophys Res Commun. 2020 Sep;530(1):10–14. https://doi.org/10.1016/j.bbrc.2020.05.206SinghTomar PPArkinITSARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and MemantineBiochem Biophys Res Commun2020Sep53011014https://doi.org/10.1016/j.bbrc.2020.05.206730588532828269Open DOISearch in Google Scholar
Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019 Jan 14;11(1):59. https://doi.org/10.3390/v11010059SongZXuYBaoLZhangLYuPQuYZhuHZhaoWHanYQinCFrom SARS to MERS, thrusting coronaviruses into the spotlightViruses2019Jan 1411159https://doi.org/10.3390/v11010059635715530646565Open DOISearch in Google Scholar
Spikevax, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Feb 20]. Available from https://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdfSpikevax, Summary of product characteristics [Internet]Amsterdam (The Netherlands)European Medicines Agency;2022[cited 2022 Feb 20]. Available fromhttps://www.ema.europa.eu/en/documents/product-information/spikevax-previously-covid-19-vaccine-moderna-epar-product-information_en.pdfSearch in Google Scholar
Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, Narykov O, Sun M, Korkin D. Structural genomics of SARS-COV-2 indicates evolutionary conserved functional regions of viral proteins. Viruses. 2020 Mar 25;12(4):360. https://doi.org/10.3390/v12040360SrinivasanSCuiHGaoZLiuMLuSMkandawireWNarykovOSunMKorkinDStructural genomics of SARS-COV-2 indicates evolutionary conserved functional regions of viral proteinsViruses2020Mar 25124360https://doi.org/10.3390/v12040360723216432218151Open DOISearch in Google Scholar
Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC, et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell. 2020 Sep;182(5):1295–1310.e20. https://doi.org/10.1016/j.cell.2020.08.012StarrTNGreaneyAJHiltonSKEllisDCrawfordKHDDingensASNavarroMJBowenJETortoriciMAWallsACet alDeep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 bindingCell2020Sep182512951310.e20https://doi.org/10.1016/j.cell.2020.08.012741870432841599Open DOISearch in Google Scholar
Suddala KC, Lee CC, Meraner P, Marin M, Markosyan RM, Desai TM, Cohen FS, Brass AL, Melikyan GB. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes. PLoS Pathog. 2019 Jan 14;15(1):e1007532. https://doi.org/10.1371/journal.ppat.1007532SuddalaKCLeeCCMeranerPMarinMMarkosyanRMDesaiTMCohenFSBrassALMelikyanGBInterferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomesPLoS Pathog2019Jan 14151e1007532https://doi.org/10.1371/journal.ppat.1007532634729830640957Open DOISearch in Google Scholar
Surjit M, Liu B, Chow VTK, Lal SK. The nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cells. J Biol Chem. 2006 Apr;281(16): 10669–10681. https://doi.org/10.1074/jbc.M509233200SurjitMLiuBChowVTKLalSKThe nucleocapsid protein of severe acute respiratory syndrome-coronavirus inhibits the activity of cyclin-cyclin-dependent kinase complex and blocks S phase progression in mammalian cellsJ Biol Chem2006Apr281161066910681https://doi.org/10.1074/jbc.M509233200799595616431923Open DOISearch in Google Scholar
Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, Wang Y, Qian Z, et al. On the origin and continuing evolution of SARS-CoV-2. Natl Sci Rev. 2020 Jun 01;7(6):1012–1023. https://doi.org/10.1093/nsr/nwaa036TangXWuCLiXSongYYaoXWuXDuanYZhangHWangYQianZet alOn the origin and continuing evolution of SARS-CoV-2Natl Sci Rev2020Jun 017610121023https://doi.org/10.1093/nsr/nwaa036710787534676127Open DOISearch in Google Scholar
Tarke A, Coelho CH, Zhang Z, Dan JM, Yu ED, Methot N, Bloom NI, Goodwin B, Phillips E, Mallal S, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell. 2022 Mar 3;185(5): 847–859.e11. https://doi.org/10.1016/j.cell.2022.01.015TarkeACoelhoCHZhangZDanJMYuEDMethotNBloomNIGoodwinBPhillipsEMallalSet alSARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to OmicronCell2022Mar 31855847859e11https://doi.org/10.1016/j.cell.2022.01.015878464935139340Open DOISearch in Google Scholar
Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, et al. Emergence and rapid spread of a new severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv. 2020;2020.12.21.20248640. https://doi.org/10.1101/2020.12.21.20248640TegallyHWilkinsonEGiovanettiMIranzadehAFonsecaVGiandhariJDoolabhDPillaySSanEJMsomiNet alEmergence and rapid spread of a new severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South AfricamedRxiv20202020.12.21.20248640https://doi.org/10.1101/2020.12.21.20248640Open DOISearch in Google Scholar
The Johns Hopkins Coronavirus Resource Center [Internet]. Baltimore (USA): Johns Hopkins University and Medicine; 2022 [cited 2022 Feb 4]. Available from https://coronavirus.jhu.eduThe Johns Hopkins Coronavirus Resource Center [Internet]Baltimore (USA)Johns Hopkins University and Medicine;2022[cited 2022 Feb 4]. Available fromhttps://coronavirus.jhu.eduSearch in Google Scholar
Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med. 2020 Apr;26(4):453–455. https://doi.org/10.1038/s41591-020-0819-2ThevarajanINguyenTHOKoutsakosMDruceJCalyLvan deSandt CEJiaXNicholsonSCattonMCowieBet alBreadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19Nat Med2020Apr264453455https://doi.org/10.1038/s41591-020-0819-2709503632284614Open DOISearch in Google Scholar
Tleyjeh IM, Kashour Z, Damlaj M, Riaz M, Tlayjeh H, Altan‑ nir M, Altannir Y, Al-Tannir M, Tleyjeh R, Hassett L, et al. Efficacy and safety of tocilizumab in COVID- 19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect. 2021 Feb; 27(2): 215–227. https://doi.org/10.1016/j.cmi.2020.10.036TleyjehIMKashourZDamlajMRiazMTlayjehHAltan‑nir MAltannirYAl-TannirMTleyjehRHassettLet alEfficacy and safety of tocilizumab in COVID- 19 patients: a living systematic review and meta-analysisClin Microbiol Infect2021Feb272215227https://doi.org/10.1016/j.cmi.2020.10.036764418233161150Open DOISearch in Google Scholar
Tomasiewicz K, Piekarska A, Stempkowska-Rejek J, Serafińska S, Gawkowska A, Parczewski M, Niścigorska-Olsen J, Łapiński TW, Zarębska-Michaluk D, Kowalska JD, et al. Tocilizumab for patients with severe COVID- 19: a retrospective, multi-center study. Expert Rev Anti Infect Ther. 2021 Jan 02;19(1):93–100. https://doi.org/10.1080/14787210.2020.1800453TomasiewiczKPiekarskaAStempkowska-RejekJSerafińskaSGawkowskaAParczewskiMNiścigorska-OlsenJŁapińskiTWZarębska-MichalukDKowalskaJDet alTocilizumab for patients with severe COVID- 19: a retrospective, multi-center studyExpert Rev Anti Infect Ther2021Jan 0219193100https://doi.org/10.1080/14787210.2020.1800453744180032693650Open DOISearch in Google Scholar
Torjesen I. COVID-19: omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear. BMJ. 2021 Nov 29;375(2943):n2943. https://doi.org/10.1136/bmj.n2943TorjesenICOVID-19: omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fearBMJ2021Nov 293752943n2943https://doi.org/10.1136/bmj.n294334845008Open DOISearch in Google Scholar
Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, Aguirre M, Gauthier L, Fleharty M, Kirby A, et al.; GTEx Consor‑ tium; Laboratory, Data Analysis &Coordinating Center (LDACC) – Analysis Working Group; Statistical Methods groups – Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Com‑ mon Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA; Biospecimen Collection Source Site – NDRI; et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017 Oct 12;550(7675):244–248. https://doi.org/10.1038/nature24265TukiainenTVillaniACYenARivasMAMarshallJLSatijaRAguirreMGauthierLFlehartyMKirbyAet alGTEx Consor‑ tium; Laboratory, Data Analysis &Coordinating Center (LDACC) – Analysis Working Group; Statistical Methods groups – Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Com‑ mon Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA; Biospecimen Collection Source Site – NDRI; et alLandscape of X chromosome inactivation across human tissues. Nature2017Oct 125507675244248https://doi.org/10.1038/nature24265568519229022598Open DOISearch in Google Scholar
Vangeel L, Chiu W, De Jonghe S, Maes P, Slechten B, Rayme‑ nants J, André E, Leyssen P, Neyts J, Jochmans D. Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Antiviral Res. 2022 Feb; 198:105252. https://doi.org/10.1016/j.antiviral.2022.105252VangeelLChiuWDeJonghe SMaesPSlechtenBRayme‑nants JAndréELeyssenPNeytsJJochmansDRemdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concernAntiviral Res2022Feb198105252https://doi.org/10.1016/j.antiviral.2022.105252878540935085683Open DOISearch in Google Scholar
Veklury, Summary of product characteristics [Internet]. Amsterdam (The Netherlands): European Medicines Agency; 2022 [cited 2022 Jan 5]. Available from https://www.ema.europa.eu/en/documents/other/veklury-product-information-approved-chmp-25-june-2020-pending-endorsement-european-commission_en.pdfVeklury, Summary of product characteristics [Internet]Amsterdam (The Netherlands)European Medicines Agency2022[cited 2022 Jan 5]. Available fromhttps://www.ema.europa.eu/en/documents/other/veklury-product-information-approved-chmp-25-june-2020-pending-endorsement-european-commission_en.pdfSearch in Google Scholar
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr;181(2):281–292.e6. https://doi.org/10.1016/j.cell.2020.02.058WallsACParkYJTortoriciMAWallAMcGuireATVeeslerDStructure, function, and antigenicity of the SARS-CoV-2 spike glycoproteinCell2020Apr1812281292e6https://doi.org/10.1016/j.cell.2020.02.058710259932155444Open DOISearch in Google Scholar
Wang W, Zhang W, Zhang J, He J, Zhu F. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19). HLA. 2020 Aug;96(2):194–196. https://doi.org/10.1111/tan.13941WangWZhangWZhangJHeJZhuFDistribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease‐2019 (COVID‐19)HLA2020Aug962194196https://doi.org/10.1111/tan.13941727686632424945Open DOISearch in Google Scholar
Wein AN, McMaster SR, Takamura S, Dunbar PR, Cartwright EK, Hayward SL, McManus DT, Shimaoka T, Ueha S, Tsukui T, et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J Exp Med. 2019 Dec 02;216(12):2748–2762. https://doi.org/10.1084/jem.20181308WeinANMcMasterSRTakamuraSDunbarPRCartwrightEKHaywardSLMcManusDTShimaokaTUehaSTsukuiTet alCXCR6 regulates localization of tissue-resident memory CD8 T cells to the airwaysJ Exp Med2019Dec 022161227482762https://doi.org/10.1084/jem.20181308688898131558615Open DOISearch in Google Scholar
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, et al.; Trial Investigators. REGEN-COV antibody combination and outcomes in outpatients with COVID- 19. N Engl J Med. 2021 Dec 02;385(23):e81. https://doi.org/10.1056/NEJMoa2108163WeinreichDMSivapalasingamSNortonTAliSGaoHBhoreRXiaoJHooperATHamiltonJDMusserBJet alTrial InvestigatorsREGEN-COV antibody combination and outcomes in outpatients with COVID- 19. N Engl J Med2021Dec 0238523e81https://doi.org/10.1056/NEJMoa2108163852280034587383Open DOISearch in Google Scholar
Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164. https://doi.org/10.1016/B978-0-12-385885-6.00009-2WeissSRLeibowitzJLCoronavirus pathogenesisAdv Virus Res20118185164https://doi.org/10.1016/B978-0-12-385885-6.00009-2714960322094080Open DOISearch in Google Scholar
WHO. Classification of Omicron (B.1.1.529): SARS‐CoV‐2 variant of concern [Internet]. Geneva (Switzerland): World Health Organization; 2021 [cited 2022 Feb 04]. Available from https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concernWHOClassification of Omicron (B.1.1.529): SARS‐CoV‐2 variant of concern [Internet]Geneva (Switzerland)World Health Organization2021[cited 2022 Feb 04]. Available fromhttps://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concernSearch in Google Scholar
WHO. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance, 19 March 2020 [Internet]. Geneva (Switzerland): World Health Organization; 2020 [cited 2022 Feb 04]. Available from https://apps.who.int/iris/handle/10665/331501WHO. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance, 19 March 2020 [Internet]Geneva (Switzerland)World Health Organization2020[cited 2022 Feb 04]Available fromhttps://apps.who.int/iris/handle/10665/331501Search in Google Scholar
WHO. Tracking SARS-CoV-2 variants [Internet]. Geneva (Switzerland): World Health Organization; 2022 [cited 2022 Feb 15]. Available from https://www.who.int/activities/tracking-SARS-CoV-2-variantsWHO. Tracking SARS-CoV-2 variants [Internet]Geneva (Switzerland)World Health Organization;2022[cited 2022 Feb 15]. Available fromhttps://www.who.int/activities/tracking-SARS-CoV-2-variantsSearch in Google Scholar
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). JAMA. 2020 Aug 25;324(8):782–793. https://doi.org/10.1001/jama.2020.12839WiersingaWJRhodesAChengACPeacockSJPrescottHCPathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)JAMA2020Aug 25;3248782793https://doi.org/10.1001/jama.2020.1283932648899Open DOISearch in Google Scholar
Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar13; 367(6483):1260–1263. https://doi.org/10.1126/science.abb2507WrappDWangNCorbettKSGoldsmithJAHsiehCLAbionaOGrahamBSMcLellanJSCryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience2020Mar13367648312601263https://doi.org/10.1126/science.abb2507716463732075877Open DOISearch in Google Scholar
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020 Mar;27(3):325–328. https://doi.org/10.1016/j.chom.2020.02.001WuAPengYHuangBDingXWangXNiuPMengJZhuZZhangZWangJet alGenome composition and divergence of the novel coronavirus (2019-nCoV) originating in ChinaCell Host Microbe2020Mar273325328https://doi.org/10.1016/j.chom.2020.02.001715451432035028Open DOISearch in Google Scholar
Xia X. Extreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defense. Mol Biol Evol. 2020 Sep 01;37(9): 2699–2705. https://doi.org/10.1093/molbev/msaa094XiaXExtreme genomic CpG deficiency in SARS-CoV-2 and evasion of host antiviral defenseMol Biol Evol2020Sep 0137926992705https://doi.org/10.1093/molbev/msaa094718448432289821Open DOISearch in Google Scholar
Xuan Y, Wang LN, Li W, Zi HR, Guo Y, Yan WJ, Chen XB, Wei PM. IFITM3 rs 12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysis. Epidemiol Infect. 2015 Oct; 143(14):2975–2984. https://doi.org/10.1017/S0950268815000278XuanYWangLNLiWZiHRGuoYYanWJChenXBWeiPMIFITM3 rs 12252 T>C polymorphism is associated with the risk of severe influenza: a meta-analysisEpidemiol Infect2015Oct1431429752984https://doi.org/10.1017/S095026881500027825778715Open DOISearch in Google Scholar
Yamayoshi S, Sakai-Tagawa Y, Koga M, Akasaka O, Nakachi I, Koh H, Maeda K, Adachi E, Saito M, Nagai H, et al. Comparison of rapid antigen tests for COVID- 19. Viruses. 2020 Dec 10;12(12):1420. https://doi.org/10.3390/v12121420YamayoshiSSakai-TagawaYKogaMAkasakaONakachiIKohHMaedaKAdachiESaitoMNagaiHet alComparison of rapid antigen tests for COVID- 19Viruses2020Dec 1012121420https://doi.org/10.3390/v12121420776451233322035Open DOISearch in Google Scholar
Yoshimoto FK. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID- 19. Protein J. 2020 Jun;39(3):198–216. https://doi.org/10.1007/s10930-020-09901-4YoshimotoFKThe proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID- 19Protein J2020Jun393198216https://doi.org/10.1007/s10930-020-09901-4724519132447571Open DOISearch in Google Scholar
Yu H, Sun B, Fang Z, Zhao J, Liu X, Li Y, Sun X, Liang H, Zhong B, Huang Z, et al. Distinct features of SARS-CoV-2-specific IgA response in COVID- 19 patients. Eur Respir J. 2020 Aug;56(2): 2001526. https://doi.org/10.1183/13993003.01526-2020YuHSunBFangZZhaoJLiuXLiYSunXLiangHZhongBHuangZet alDistinct features of SARS-CoV-2-specific IgA response in COVID- 19 patientsEur Respir J2020Aug5622001526https://doi.org/10.1183/13993003.01526-2020723682132398307Open DOISearch in Google Scholar
Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, Lu G, Wu Y, Yan J, Shi Y, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017 Apr;8(1):15092. https://doi.org/10.1038/ncomms15092YuanYCaoDZhangYMaJQiJWangQLuGWuYYanJShiYet alCryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domainsNat Commun2017Apr8115092https://doi.org/10.1038/ncomms15092539423928393837Open DOISearch in Google Scholar
Yüce M, Filiztekin E, Özkaya KG. COVID- 19 diagnosis – A review of current methods. Biosens Bioelectron. 2021 Jan;172:112752. https://doi.org/10.1016/j.bios.2020.112752YüceMFiliztekinEÖzkayaKGCOVID- 19 diagnosis – A review of current methodsBiosens Bioelectron2021Jan172112752https://doi.org/10.1016/j.bios.2020.112752758456433126180Open DOISearch in Google Scholar
Zang R, Castro MFG, McCune BT, Zeng Q, Rothlauf PW, Sonnek NM, Liu Z, Brulois KF, Wang X, Greenberg HB, et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020 May 19;5(47): eabc3582. https://doi.org/10.1126/sciimmunol.abc3582ZangRCastroMFGMcCuneBTZengQRothlaufPWSonnekNMLiuZBruloisKFWangXGreenbergHBet alTMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytesSci Immunol2020May 19547eabc3582https://doi.org/10.1126/sciimmunol.abc3582728582932404436Open DOISearch in Google Scholar
Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Mohammed A, Zhao C, Yang Y, Xie J, et al. Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun. 2020 Jun;527(3):618–623. https://doi.org/10.1016/j.bbrc.2020.04.136ZengWLiuGMaHZhaoDYangYLiuMMohammedAZhaoCYangYXieJet alBiochemical characterization of SARS-CoV-2 nucleocapsid proteinBiochem Biophys Res Commun2020Jun5273618623https://doi.org/10.1016/j.bbrc.2020.04.136719049932416961Open DOISearch in Google Scholar
Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K, Liang L, Zhang C, Dai Y, Feng Y, et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J Infect Dis. 2020 Jun 16;222(1):34–37. https://doi.org/10.1093/infdis/jiaa224ZhangYQinLZhaoYZhangPXuBLiKLiangLZhangCDaiYFengYet alInterferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019J Infect Dis2020Jun 1622213437https://doi.org/10.1093/infdis/jiaa224719755932348495Open DOISearch in Google Scholar
Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021 Jul 15;73(2):328–331. https://doi.org/10.1093/cid/ciaa1150ZhaoJYangYHuangHLiDGuDLuXZhangZLiuLLiuTLiuYet alRelationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibilityClin Infect Dis2021Jul 15732328331https://doi.org/10.1093/cid/ciaa1150745437132750119Open DOISearch in Google Scholar
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020 Sep 01;202(5):756–759. https://doi.org/10.1164/rccm.202001-0179LEZhaoYZhaoZWangYZhouYMaYZuoWSingle-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2Am J Respir Crit Care Med2020Sep 012025756759https://doi.org/10.1164/rccm.202001-0179LE746241132663409Open DOISearch in Google Scholar
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, Li Q, Jiang C, Zhou Y, Liu S, et al. Risk factors of critical and mortal COVID- 19 cases: A systematic literature review and meta-analysis. J Infect. 2020 Aug;81(2):e16–e25. https://doi.org/10.1016/j.jinf.2020.04.021ZhengZPengFXuBZhaoJLiuHPengJLiQJiangCZhouYLiuSet alRisk factors of critical and mortal COVID- 19 cases: A systematic literature review and meta-analysisJ Infect2020Aug812e16e25https://doi.org/10.1016/j.jinf.2020.04.021717709832335169Open DOISearch in Google Scholar
Zhou X, Cheng Z, Shu D, Lin W, Ming Z, Chen W, Hu Y. Characteristics of mortal COVID-19 cases compared to the survivors. Aging (Albany NY). 2020 Dec 31;12(24):24579–24595. https://doi.org/10.18632/aging.202216ZhouXChengZShuDLinWMingZChenWHuYCharacteristics of mortal COVID-19 cases compared to the survivorsAging (Albany NY)2020Dec 3112242457924595https://doi.org/10.18632/aging.202216780352833234724Open DOISearch in Google Scholar
Zipeto D, Palmeira JF, Argañaraz GA, Argañaraz ER. ACE2/ ADAM17/TMPRSS2 Interplay may be the main risk factor for COVID-19. Front Immunol. 2020 Oct 7;11:576745. https://doi.org/10.3389/fimmu.2020.576745ZipetoDPalmeiraJFArgañarazGAArgañarazERACE2/ ADAM17/TMPRSS2 Interplay may be the main risk factor for COVID-19Front Immunol2020Oct 711576745https://doi.org/10.3389/fimmu.2020.576745757577433117379Open DOISearch in Google Scholar
Zou J, Yin J, Fang L, Yang M, Wang T, Wu W, Bellucci MA, Zhang P. Computational prediction of mutational effects on SARS-CoV-2 binding by relative free energy calculations. J Chem Inf Model. 2020 Dec 28;60(12):5794–5802. https://doi.org/10.1021/acs.jcim.0c00679ZouJYinJFangLYangMWangTWuWBellucciMAZhangPComputational prediction of mutational effects on SARS-CoV-2 binding by relative free energy calculationsJ Chem Inf Model2020Dec 28601257945802https://doi.org/10.1021/acs.jcim.0c00679746086432786709Open DOISearch in Google Scholar
Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): A perspective from China. Radiology. 2020 Aug;296(2):E15–E25. https://doi.org/10.1148/radiol.2020200490ZuZYJiangMDXuPPChenWNiQQLuGMZhangLJCoronavirus disease 2019 (COVID-19): A perspective from ChinaRadiology2020Aug2962E15E25https://doi.org/10.1148/radiol.2020200490723336832083985Open DOISearch in Google Scholar
, , und | 19. Juni 2022